Last reviewed · How we verify
NCT03477448
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
Phase 4 trial testing Bleomycin in Warts in 40 participants. Status unknown.
1 April 2019
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 40 |
| Start date | 1 April 2018 |
| Primary completion | 1 April 2019 |
| Estimated completion | 1 April 2020 |
Drugs / interventions tested
- Bleomycin (BLEOMYCIN) — full drug profile →
- Purified Protein Derivative — full drug profile →
Conditions studied
- Warts — all drugs for Warts →
Sponsor
Assiut University
Who can join
Adults 15 to 40, any sex, with Warts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
* Warts are common viral infections on the skin and are prevalent worldwide. Warts are caused by the human Papilloma virus (HPV), which has more than 100 strains; some of them are known to be premalignant. Although warts can appear at any age, they are more common in children and adolescents. The prognosis of warts cannot be predicted. In some patients they may spontaneously disappear, whereas others show persistence and progression with spreading to other body sites, leading to physical and emotional distress to the patients. * Factors that increase the risk include use of public showers, working with meat, eczema, and a low immune system . The virus is believed to enter the body through skin that has been damaged slightly . A number of types exist including: common warts, plantar warts, filiform warts, and genital warts . Genital warts are often sexually transmitted.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03477448
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bleomycin
Trials testing the same drug.
- NCT07041749 — Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Wart · NA · not yet recruiting
- NCT07320001 — Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations · Phase 2 · not yet recruiting
- NCT06647342 — The Effect of Reduced Bleomycin in Electrochemotherapy Treatment · Phase 4 · recruiting
- NCT06189092 — Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study · recruiting
- NCT06437158 — Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients · Phase 2 · recruiting
Other recruiting trials for Warts
Currently open trials in the same condition.
- NCT07534865 — Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts · NA · recruiting
- NCT06827938 — Multicenter Real-World Study of Hyperthermia in Warts of Special Population · NA · recruiting
- NCT06812065 — Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts · NA · recruiting
- NCT05291845 — Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts · Phase 2 · recruiting
- NCT00967785 — A Phase I Study of Mozobil in the Treatment of Patients With WHIMS · Phase 1, PHASE2 · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03477448 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 26 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03477448.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing